3 Results for "

JAK1-IN-10

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "JAK1-IN-10" in MCE Product Catalog:

Cat. No.: HY-153566
CAS No.: 2416858-88-1
Target:  

JAK

Research Areas:  

Cancer

JAK1-IN-10 (compound 9), a cyano-substituted cyclic hydrazine derivative, is a potent and selective JAK1 inhibitor .
loading...
    loading...
Cat. No.: HY-112724
CAS No.: 1445987-21-2
Purity:  99.82%
Synonyms: SHR0302
Target:  

JAK Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Ivarmacitinib (SHR0302) is a potent and orally active all members of the JAK family inhibitor, particularly JAK1. The selectivity of Ivarmacitinib for JAK1 is >10-fold for JAK2, 77-fold for JAK3, 420-fold for Tyk2. Ivarmacitinib inhibits JAK1-STAT3 phosphorylation and induces the apoptosis of hepatic stellate cells. Ivarmacitinib has anti-proliferative and anti-inflammatory effects .
loading...
    loading...
Cat. No.: HY-112724A
CAS No.: 1639419-51-4
Synonyms: SHR0302 sulfate
Target:  

JAK Apoptosis

Research Areas:  

Inflammation/Immunology Cancer

Ivarmacitinib (SHR0302) sulfate is a potent and orally active all members of the JAK family inhibitor, particularly JAK1. The selectivity of Ivarmacitinib for JAK1 is >10-fold for JAK2, 77-fold for JAK3, 420-fold for Tyk2. Ivarmacitinib inhibits JAK1-STAT3 phosphorylation and induces the apoptosis of hepatic stellate cells. Ivarmacitinib has anti-proliferative and anti-inflammatory effects .
loading...
    loading...